A standardised African mango seed extract studied for weight and metabolic health markers Furoslim™ is a branded extract derived from the seeds of Irvingia gabonensis, a West African plant commonly referred to as African mango or bush mango. The seeds have a long history of traditional dietary use in West Africa, where they are valued for their thickening properties and satiating effect when consumed as part of meals. In modern research, Irvingia gabonensis seed extracts have been investigated for their potential role in supporting body weight management and metabolic health markers in overweight individuals. Human clinical studies have explored changes in body weight, waist circumference, lipid markers, and glucose-related parameters, positioning the ingredient within a broader metabolic health context. The seed kernels of Irvingia gabonensis contain a combination of soluble fibre, protein fractions, and other bioactive constituents. Furoslim™ is standardised to 8% albumin, a seed protein fraction that has been discussed in the literature in relation to satiety signalling and metabolic regulation. Standardisation ensures a consistent composition and supports reproducibility across batches and finished formulations. Furoslim™ is a concentrated seed extract designed for use in food supplement formulations. While the exact phytochemical profile of Irvingia gabonensis seeds is complex, analytical characterisation typically focuses on: This compositional profile underpins the ingredient’s positioning in weight and metabolic health applications. Research into Irvingia gabonensis seed extracts has explored several physiological pathways relevant to metabolic health, including: These pathways are discussed in the scientific literature as part of broader investigations into dietary fibres and seed-derived bioactives, and they provide a contextual framework for interpreting human study outcomes. Randomised, double-blind, placebo-controlled trials conducted in overweight adult populations have reported statistically significant reductions in body weight and waist circumference following supplementation with Irvingia gabonensis seed extract over intervention periods of approximately 8–12 weeks. These changes were observed alongside dietary guidance and are consistent with the ingredient’s proposed role in supporting weight management strategies. The same clinical investigations reported improvements in several metabolic markers, including: These findings suggest a broader metabolic context beyond body weight alone, although outcomes vary between studies. Systematic reviews of randomised controlled trials have concluded that, while individual studies report positive outcomes, the overall evidence base for Irvingia gabonensis remains limited by the number of trials and variability in study design and reporting quality. As such, findings should be interpreted within the context of a developing evidence base. Across published human studies and reviews, Irvingia gabonensis seed extract has generally been described as well tolerated when consumed by healthy adults over short- to medium-term study periods. Reported adverse effects have typically been mild and transient, most commonly involving gastrointestinal discomfort or headache in a small number of participants. No serious safety concerns have been identified in the available clinical literature. Based on its composition and published human research, Furoslim™ may support: These potential benefits reflect trends observed in controlled human studies and are influenced by overall dietary and lifestyle context. Furoslim™ is commonly formulated at a 250 mg daily serving in food supplement products. Furoslim™ is a standardised Irvingia gabonensis (African mango) seed extract characterised by its 8% albumin content and investigated in human clinical research focused on weight and metabolic health markers. Controlled trials have reported reductions in body weight and waist circumference, alongside improvements in selected metabolic parameters, while systematic reviews highlight the need for further high-quality research. When used as part of a balanced diet and healthy lifestyle, Furoslim™ represents a botanically derived ingredient positioned for weight and metabolic health support with an emerging, but still developing, evidence base. Furoslim® is available as a single-ingredient formulation here.Furoslim™ (Irvingia gabonensis Seed Extract)
Introduction
Botanical identity and standardisation
Composition and analytical characterisation
Evidence context and proposed pathways
Human clinical research
Body weight and waist circumference
Metabolic and lipid markers
Evidence quality considerations
Safety and tolerability
Potential benefits (evidence-led)
Typical intake
Summary
References
